Weekly Injectable Drug Offers Hope for Parkinson's Patients

Researchers at the University of South Australia have developed a long-acting injectable gel that could transform how Parkinson’s disease is treated — potentially replacing the need for multiple daily pills with a once-weekly injection. 💉 How It Works The new formulation delivers a steady dose of levodopa and carbidopa — the gold-standard medications for Parkinson’s — over seven days. The gel is biodegradable and can be injected under the skin or into muscle using a fine needle. It gradually releases medication, helping to maintain stable drug levels in the body. 🧠 Why This Matters for People with Parkinson’s People living with Parkinson’s often need to take medications several times a day, which can be difficult — especially for older adults or those with swallowing issues. Frequent dosing can cause inconsistent medication levels, more side effects, and reduced effectiveness. A weekly injection could improve treatment consistency, reduce symptoms, and make life easier for people managing the disease. 🔬 What the Research Shows ✅ In lab tests, more than 90% of levodopa and 81% of carbidopa were steadily released over a week. ✅ The gel degraded naturally and showed no toxicity in safety tests. ✅ The injection is minimally invasive and does not require surgery. 🌍 Looking Ahead The research team has filed a patent in Australia and is preparing for clinical trials. They also believe this technology could be adapted for other chronic illnesses, including diabetes, cancer, and pain management. 🕊️ A Step Toward Easier, More Reliable Care This weekly injection isn't just about convenience — it could offer people with Parkinson’s a more predictable, dignified, and manageable treatment experience, especially in the advanced stages of the disease.